Objective: This study aims to examine the accuracy of a new sternal skin conductance (SSC) device in measuring hot flashes and to assess the acceptability of the device by women.
H ot flashes are one of the most common and most distressing symptoms of menopause, occurring in more than 75% of postmenopausal women. 1 Although they are not life-threatening, hot flashes can have a significant negative impact on functional ability and quality of life. Hot flashes are especially problematic for breast cancer survivors, as they can be precipitated by premature menopause due to chemotherapy and antiestrogenic medications.
Several effective treatments of hot flashes have been identified using retrospective and prospective self-report measures. Hormone therapy is the most effective treatment of hot flashes, and treatment with estrogen compounds can decrease hot flashes by 80% to 90%. 2 However, owing to its possible risks, estrogen has been recommended to be used at the lowest possible dose and for the shortest time, and to be avoided in breast cancer survivors. Other therapies, including serotonergic antidepressants and gabapentin, have shown benefits for the treatment of hot flashes with decreases around 50% to 60%, 3 yet the search for a more effective treatment of hot flashes continues, with the goals being higher efficacy and better adverse effect profiles. Hot flash measurement could be improved to facilitate the discovery of better treatments.
Multiple tools are currently being used in clinical research for the assessment of hot flashes. Subjective self-reported data in the form of questionnaires or diaries are the most common method of measurement. Early studies used a recollectiontype questionnaire in which women would retrospectively report hot flashes during the past several days. This method was fraught with inaccuracy and bias. Hot flash diary was more recently developed as a prospective, real-time measurement of hot flashes. This diary is a well-accepted method for measuring hot flashes, having been successfully used in multiple trials evaluating pharmacologic treatments. 4 Event monitors are another method of subjective self-reporting where women record a hot flash as it occurs by pushing a button on a device. Recently, there has been concern that subjective self-reporting of hot flashes may be subject to bias and underreporting and/or overreporting. As a result, there has been an interest in finding an appropriate objective measure of hot flashes. 5 The development of a valid physiologic surrogate measure for hot flashes is challenging owing largely to the fact that the physiology of hot flashes is not definitively known. Currently, the most studied method of objectively measuring hot flashes is sternal skin conductance (SSC). Previous studies have shown that hot flashes are accompanied by large changes in skin conductance, and increased SSC was noted to precede changes in peripheral or core temperature. 6, 7 Early studies in laboratory settings reported a high correlation between SSC and selfreported hot flashes. 7, 8 Based on these studies, a 2-Kmho increase in SSC within a 30-second period was associated with a self-reported hot flash. 7, 9 Although early studies supported the correlation between subjective hot flashes and devicerecorded hot flashes, later studies, particularly in ambulatory settings, have failed to demonstrate such high levels of concordance. 10, 11 Consequently, the use of SSC in hot flash clinical trials remains controversial. 5, 11 The most commonly used SSC monitor is BioLog 3991, which is composed of electrodes attached to the sternum and transmitted through lead wires to a BioLog monitor, which is worn over clothing, such as on a belt. The monitor cannot be used while bathing; it is large and, therefore, can interfere with daily activities. In addition, its recording capacity is limited to 24 hours, and the device costs around US$2,300 each. 12 In 2004, a request for application, entitled BImproving Measurement Tools for Sternal Skin Conductance and Hot Flashes,[ was released. This request for application offered small business innovation research grants for research on improving measurement tools or devices for SSC. An engineering device company in the Midwest received one of these grants and developed a new SSC device. The device was smaller and lighter than the BioLog 3991. The new device attaches directly to the participant using a standard electrode adhesive pad and has short leads to two electrodes. In addition, the device was developed to record data for a minimum of 4 weeks between battery charges. However, it still could not be worn while showering or bathing. The engineering device company was awarded two grants initially, which resulted in two prototypes, with the second building on knowledge from the first.
Three pilot studies were performed to determine the tolerability and efficacy of these new devices in the measurement of hot flashes. The first study measured the initial prototype in a laboratory-type setting for 24 hours and in an ambulatory setting for 5 weeks. The second prototype was tested in a monitored setting for 24 hours to evaluate the sensitivity and specificity of this improved device. This article aims to report on the clinical testing of these two initial prototypes.
METHODS
All trials involved postmenopausal women who reported bothersome hot flashes (defined as occurrence Q4 times per day). Daily hot flashes had to be present for 1 month or more immediately before study entry. Participants had to be 18 years or older, with excellent performance status. Women were not eligible if they had a history of allergic or adverse reaction to adhesives, were currently using implanted pacemakers or metal implants, or were currently relying on electronic devices for regular monitoring (ie, insulin pumps or blood pressure monitors). Volunteers for the study were recruited through advertisements inside Mayo Clinic (Rochester, MN) and the surrounding community. Women received payment for their time and effort because this study did not offer an intervention.
The first set of trials used the first prototype of the skin conductance monitor. One study was developed with two phases. As this was a feasibility study related to the function of the device and did not involve an intervention, we wanted to keep the sample size as small as possible to meet the objective, hence minimizing burden. Therefore, we estimated a sample size of 20: 3 women for the 24-hour overnight phase and 17 for the outpatient phase. The three women participating in the overnight phase were admitted to the General Clinical Research Center (GCRC) facility, and the hot flash monitor was connected to the participants. The women wore the SSC device for 24 hours, even during a 30-minute treadmill exercise test. A hot flash diary was completed continuously for 24 hours, and a comfort, bother, and weight questionnaire was completed at the end of the GCRC stay. Another pilot trial of the first prototype investigated the use of the hot flash monitor in an ambulatory setting. Eligible women were provided a skin conductance hot flash device and were instructed to wear it for 5 weeks. They were also given a hot flash diary to fill out daily in real time, as well as a comfort, bother, and weight questionnaire to complete at the end of week 5. The monitors were initially attached by study personnel. Participants would remove the device once daily for showering. The times the device was unattached and reattached were recorded in the diary. Each woman was contacted by the study nurse or other research personnel by telephone weekly during weeks 1 to 5 to determine compliance, to ask questions, and to encourage continued completion of the booklet. The study used the Common Terminology Criteria for Adverse Events for adverse event monitoring and reporting. The goals of these studies were to determine whether hot flash frequency, as measured by the skin conductance measuring and recording tool, correlates with self-recorded hot flash frequency per hot flash diary in a controlled and ambulatory setting. It also aimed to evaluate the comfort and obtrusiveness of using the skin conductance recording tool for 5 weeks. The last trial used the same methodology as the first trial, including 24-hour monitoring in the GCRC, but used the second prototype of the device with upgrades based on what was learned in the first set of trials.
Data recordings from the device were reviewed for each participant, and any rapid increase in skin conductance was identified. Based on previous data reported by Freedman, 7 a hot flash was defined as an increase in skin conductance level of 2 Kmho or higher within a 30-second period. The deviceidentified hot flash has a quick spike with a slow decent. If the increase in skin conductance seemed to have a quick spike but was lower than 2 Kmho, it was identified but not counted as an objective hot flash. Hot flash diaries were reviewed; if the device-identified hot flash was within 10 minutes of the diaryrecorded hot flash, they were considered to be concordant. There is no known accepted criterion for the timing of a diaryrecorded hot flash and an SSC-recorded hot flash.
Descriptive statistics were used. Concordance rates were calculated as the percentage of hot flashes identified by both SSC device and self-reported diaries. Underreported hot flashes were those that were recorded on the SSC device but not on women's diary. Overreported hot flashes were those that were recorded by women but not identified by the SSC device. Sensitivity was calculated as the proportion of SSC-defined hot flashes that were also reported by the woman divided by the total number of SSC-defined hot flashes. In these calculations, SSC-measured hot flashes were used as referent measure.
RESULTS

SSC prototype 1
All three participants enrolled in the first study spent 24 hours in the GCRC and completed the protocol. The median age of the participants was 53 years. Seventeen women, with a mean age of 57 years, were enrolled in the second study. They all wore the device for 5 weeks; one woman had missing data, which were reportedly lost in the mail. Overall, the device was well tolerated, although 5 of 17 (31%) reported that it prevented them from doing activities, specifically showering/bathing, air travel, sex, and water aerobics. Thirteen of 17 (81%) women reported that they would prefer to wear a device rather than fill out a hot flash diary. Unfortunately, hot flash data could not be derived from the first prototype because special conductance gel was not used and electrode patches were not able to appropriately pick up conductance.
SSC prototype 2
Three women were enrolled in this trial, and all participants spent 24 hours in the GCRC. Despite the use of conductance gel, only one device recorded an entire 24 hours of data. The other two participants had device data for 5 and 6 hours, respectively. The device recorded during exercise for all women. Table 1 reviews the concordance rate and sensitivity of the device. Twenty-one hot flashes were recorded in the daily diaries for 24 hours. Five diary-recorded hot flashes were detected by the device, resulting in a concordance rate of 24%. Six diary-recorded hot flashes corresponded with a rapid rise in skin conductance (G2 Kmho). Therefore, if the recordings were judged using a less strict spike criterion (G2 Kmho in magnitude), then 11 diary-recorded hot flashes were identified by the device. Samples of data from the skin conductance device are shown in Figure 1 .
Overall, wearing the device was acceptable; two of three women would prefer to wear the device rather than keep a hot flash diary. However, one woman reported that the device affected her ability to shower and the electrodes made her skin itchy.
DISCUSSION
Despite improvements made on the first prototype, the device functioned as expected on only one patient during the study period. However, we were able to collect data on the acceptability of wearing this device in the outpatient setting for 5 weeks. This is the longest period that an SSC device has been worn in an ambulatory setting, as previous studies of SSC devices had women wearing them for only 24-to 36-hour periods. This study shows that it is feasible and acceptable for women to wear a small device in the outpatient setting for a 5-week period without significant impairment in their quality of life. However, women still reported some difficulties with wearing the monitor, including interference with bathing, traveling, and sex, and limitation of clothing selection. In addition, some developed skin irritation from adhesives, and many women still found the device to be bulky and requested for a smaller, more discrete monitor. Interestingly, women preferred wearing the device to keeping a paper diary for capturing their hot flashes in real time.
Overall, the SSC device proved to be unreliable. There were limited data for determining the concordance rate, which demonstrated that only 24% of hot flashes recorded by women were identified by the device as a rise in conductance higher than 2 Kmho. Although early studies reported a high concordance between SSC-recorded and self-reported hot flashes, 7, 9 more recent studies reported significantly lower concordance rates. 10, 13, 14 A recent meta-analysis included 24 studies that used SSC monitors to measure hot flashes and found that the overall concordance rates between objective and subjective measurements of hot flashes were low (around 29%), although there was significant heterogeneity between studies. 10 This is similar to the rate in this study.
Underreporting (hot flashes recorded by the SSC monitor but not recorded by women) is a common cause of discordance between objective and subjective hot flash measurements, with rates between 17% and 42%, depending on the setting and time of day. 10 However, there are multiple possible explanations for the occurrence of underreporting. One possibility is that women do not document all of their experienced hot flashes owing to forgetting, noncompliance, or inability to document because of circumstances (driving, sleeping, etc). This theory can be supported by evidence indicating that concordance rates in a nonambulatory setting improve when women have less distracting factors. 10 In addition, concordance rates tend to decrease during sleep, a time when women may not wake up to record their hot flashes. 15, 16 However, another possibility is that women do not perceive these episodes as hot flashes and therefore do not record them. In addition, other traits, such as coping style or optimism, may affect reporting. 17 Moreover, as SSC measures skin conductance induced by sweating and/or sympathetic activation, it is possible that the SSC-documented hot flashes not recorded by women were not truly hot flashes but conductance changes related to other causes of sympathetic activation. In our study, three women wore the SSC monitor during physical exercise and had recorded activities on the monitor that had similarities to those recorded during a hot flash (Fig. 1) . This is the only study, to our knowledge, to record SSC data during exercise. However, an older study reported that premenopausal women had hot flashes recorded on the SSC device when they did not subjectively report the hot flashes and that these occurred with exertion and stress. These recorded hot flashes were similar to the hot flashes seen in postmenopausal women. 18 It has been proposed that spikes recorded by the SSC device must be true hot flashes because they met the 2-Kmho change and were similar in appearance to previous hot flashes that were concordant with hot flashes recorded by women. 18 Yet, there remains a lack of evidence that the recorded SSC spikes are not a result of other causes of sympathetic activation.
Another cause of decreased concordance rates between SSC and subjective reporting are hot flashes recorded by women but not recorded by the deviceVreferred to as overreporting or false-positives; this is the most significant contributing factor to the low concordance in our study. However, this must be interpreted carefully. One possible explanation for this occurrence is that women truly overreport hot flashes. This is supported by data indicating that false-positive hot flash reports are more probable after elevated frustration and decreased feelings of control. 19 However, it may also be that the SSC device is not sensitive enough to record mild hot flashes. One study showed that nearly 50% of subjective distress from hot flashes occurred when the SSC magnitude was less than the established cutoff point of 2 Kmho within 30 seconds. 6 In our study, six of the subjectively recorded hot flashes occurred with changes in SSC magnitude lower than 2 Kmho (Fig. 1) , and most hot flashes recorded by women but not by the SSC monitor were rated as mild. These findings are consistent with other studies showing that subjectively reported hot flashes not documented on the SSC monitor tend to be mild or moderate, not severe. 13 In addition, differences in the sensitivity of SSC monitoring can arise based on the electrolyte media used for the measurements. 20 Moreover, rises in skin conductance have varying appearances, as shown in Figure 1 . Although there have been proposed recommendations for the interpretation of SSC monitoring, there seems to be a lack of any definitive algorithm for defining a hot flash, making interpretation of the data difficult.
Another important limitation of SSC monitors is that they do not provide any data on severity. Severity is important in the measurement of hot flashes, as severity ratings take into account different aspects of the hot flash experience, including duration, physical symptoms, emotional symptoms, and interference with functioning. It has been shown that hot flash severity is directly related to greater perceived hot flash interference, measured via the Hot FlashYRelated Daily Interference Scale. 21 Currently, SSC monitors have no ability to measure hot flash severity or distress. Carpenter et al 6 investigated this relationship and reported that the amount of change in SSC during the 30-second rise associated with each hot flash did not correspond to subjective hot flash intensity.
CONCLUSIONS
Overall, the accuracy and utility of SSC in the measurement of hot flashes are controversial, and recent data show that, in addition to technical issues, the use of skin conductance as a physical surrogate for hot flashes may not be as specific a measure as required for rigorous studies. Recently, a large trial involving 395 breast cancer survivors collected hot flash data for 24 to 36 hours using SSC, event monitors, and selfreported dairies. Researchers, including leaders in the field of hot flash measurement, reported that the objective measurement with SSC had considerable measurement error and may be a less reliable indicator of hot flash symptoms than self-reports. 11 Meanwhile, studies continue to demonstrate effective interventions for hot flashes, 22<24 and women continue to articulate their need for treatment of this bothersome symptom. Therefore, if the need for a valid physiologic measure is still deemed important for hot flash research to continue, it is time to identify a more reliable and specific surrogate.
